Tuesday 16th May 2017

AMRC membership boosts our investment in research

We at SRUK have been working towards becoming members of the Association of Medical Research Charities (AMRC) over the past year and are pleased to announce that our application was accepted at the end of April. This is a great achievement for the charity, as membership is the hallmark of quality research funding and considerably increases the value of grants that we award.

Read Article

Friday 12th May 2017

Anticentromere antibodies associated with better outcomes

Organ involvement occurs later in people with diffuse scleroderma and anticentromere antibodies (ACAs).

Read Article

Thursday 11th May 2017

Drugs target cell pathways altered in scleroderma

Evidence suggests drugs in scleroderma trials have beneficial effects on skin, lung function and the heart.

Read Article

Tuesday 9th May 2017

Mental Health Awareness Week

Read Article

Friday 5th May 2017

Prescription charges and people with long-term conditions

We're calling for a clear commitment from the government to review and reform the medical exemption criteria for prescription charges, which was compiled in 1968 and will be 50 years old next year, to include all those with long-term conditions.

Read Article

Wednesday 3rd May 2017

Looking after your mental health

There is a link between long-term physical health conditions, such as Raynaud’s phenomenon and scleroderma, and mental health problems such as depression, is well known. According to the Department of Health, more than 15 million people in England – 30% of the population – have one or more long-term conditions,1 and evidence suggests at least 30% of people with a long-term physical health condition also have a mental health condition.2 If you are struggling, you are therefore not alone.

Read Article

Thursday 26th May 2016

Cytori Fully Enrols Pivotal US Phase III Scleroderma Trial

Cytori Therapeutics Inc. announces that its US FDA-approved phase III STAR trial has enrolled its 80th patient (100% of target enrolment). All 80 patients enrolled thus far in both trial arms have been successfully treated without complications. Full trial data are expected to be available in mid-2017.

Read Article

Wednesday 25th May 2016

Everyone has a story, here's mine...

Read Article

Monday 23rd May 2016

Report: British Society for Rheumatology (BSR) Conference 2016

On Tuesday 26th through to the 28th of April, The British Society for Rheumatology held their annual conference, with this year’s venue being in Glasgow.

Read Article

Saturday 21st May 2016

Chemotherapy Isn't Only for Cancer

When you hear the word chemotherapy what immediately comes to mind? Cancer. Bald. Nausea. Vomiting. Infusions. Sterility. Bone Pain?

Read Article